CVF, LLC

Business address
222 North Lasalle Street, Suite 2000, Chicago, IL, 60601
Top holdings (ownership)
GUTS
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
CVF, LLC has filed 29 SEC EDGAR filings since 21 Apr 2000

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
SCHEDULE 13G/A Open Document Open Filing 12 Feb 2025
SC 13G/A Open Document Open Filing SC 13G/A 07 Nov 2024
SC 13G Open Document Open Filing SC 13G 14 Feb 2024
4 Open Document Open Filing FORM 4 SUBMISSION 06 Feb 2024 06 Feb 2024 001-41942
3 Open Document Open Filing FORM 3 SUBMISSION 01 Feb 2024 01 Feb 2024 001-41942
SC 13G/A Open Document Open Filing SC 13G/A 10 Feb 2023
SC 13G/A Open Document Open Filing SC 13G/A 10 Feb 2023
SC 13G/A Open Document Open Filing SC 13G/A 10 Feb 2022
SC 13G Open Document Open Filing SC 13G 10 Feb 2022
SC 13G/A Open Document Open Filing SC 13G/A 05 Feb 2021
SC 13G Open Document Open Filing COMPLETE SUBMISSION TEXT FILE 20 Nov 2020
SC 13G/A Open Document Open Filing SCHEDULE 13G/A 09 Feb 2018
3 Open Document Open Filing FORM 3 - 19 Jul 2017 19 Jul 2017 001-38150
4 Open Document Open Filing FORM 4 SUBMISSION 05 Jul 2017 05 Jul 2017 001-38130
3 Open Document Open Filing FORM 3 SUBMISSION 28 Jun 2017 28 Jun 2017 001-38130
SC 13G/A Open Document Open Filing SCHEDULE 13G AMENDMENT NO. 2 10 Feb 2017
SC 13G/A Open Document Open Filing CERULEAN PHARMA INC. SCHEDULE 13G/A 10 Feb 2016
SC 13G/A Open Document Open Filing GENOCEA BIOSCIENCES, INC. SCHEDULE 13G/A 10 Feb 2016
4 Open Document Open Filing OWNERSHIP DOCUMENT 09 Apr 2015 07 Apr 2015 001-36395
SC 13G Open Document Open Filing CERULEAN PHARMA INC. SCHEDULE 13G 17 Feb 2015
SC 13G Open Document Open Filing GENOCEA BIOSCIENCES, INC. SCHEDULE 13G 17 Feb 2015
4 Open Document Open Filing PRIMARY DOCUMENT 16 Apr 2014 15 Apr 2014 001-36395
3 Open Document Open Filing PRIMARY DOCUMENT 10 Apr 2014 10 Apr 2014 001-36395